Press Release: Chembio : Shareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with Biosynex

Chembio is a New York-based company that designs, manufactures and markets point-of-care diagnosing products to detect infectious diseases for the healthcare sector.